Aehr Test Systems Stock Soars After Q4 Results — Here's Why

Benzinga Earnings
07/15

Aehr Test Sytems (NASDAQ:AEHR) stock soared after the company posted fourth-quarter results after Tuesday’s closing bell, beating estimates on the top and bottom lines.  

Here’s a look at the details inside the report. 

  • AEHR stock is moving. Watch the price action here.

Aehr Test Systems Q4 Details       

Aehr Test Systems reported quarterly earnings of 11 cents per share, which beat the analyst consensus estimate for a loss of one cent, according to Benzinga Pro data.

Quarterly revenue clocked in at $18.84 million, which beat the Street estimate of $18.69 million and was up from $14.09 million in the same period last year.

Aehr reported the following quarterly highlights:

  • Net revenue was $18.8 million, compared to $14.1 million in the fourth quarter of fiscal 2025.
  • Bookings were a record $60.7 million for the quarter.
  • Backlog as of May 29, 2026, was $80.6 million. Effective backlog, including bookings since May 29, 2026, is $100.6 million.

“We are very pleased with our fiscal fourth quarter performance, which exceeded expectations and capped a year of significant bookings and revenue diversification for Aehr,” CEO Gayn Erickson said.

“Record quarterly bookings, a very strong backlog, and growing demand across AI processors, silicon photonics and power semiconductors for our wafer-level and package-level burn-in solutions position us well for significant growth moving forward,” Erickson added.

Read Also: IBM Heads for Worst Day Ever, But Why Are Cybersecurity Stocks Up?

Looking Ahead

Aehr expects fiscal 2027 revenue in a range of $130 million to $150 million, versus the $85.13 million analyst estimate.

AEHR Stock Price Activity: According to data from Benzinga Pro, Aehr Test Systems stock was up 23.29% to $88.78 in Tuesday’s extended trading.  

Photo: Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10